SCHEMBL6689929

SCHEMBL6689929

CCCCC(=O)Oc1ccc(C)cc1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 9/20 0.57
LMNA P02545 3/20 0.53
ALDH1A1 P00352 2/20 0.53
HSD17B10 Q99714 2/20 0.53
MAPT P10636 1/20 0.53
HTT P42858 1/20 0.53
MEN1 O00255 4/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
GAA P10253 1/20 0.51
BCL9 O00512 1/20 0.50
CTNNB1 P35222 1/20 0.50
KDM4E B2RXH2 1/20 0.49
RECQL P46063 1/20 0.49
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5326389 0.95 KMT2A (0.58) KMT2ALMNAALDH1A1HSD17B10MAPT
SCHEMBL10956010 0.93 KMT2A (0.61) KMT2ALMNAALDH1A1HSD17B10MAPT
SCHEMBL13763454 0.93 KMT2A (0.61) KMT2ALMNAALDH1A1HSD17B10MAPT
SCHEMBL13401891 0.93 KMT2A (0.61) KMT2ALMNAALDH1A1HSD17B10MAPT
SCHEMBL3505506 0.93 KMT2A (0.61) KMT2ALMNAALDH1A1HSD17B10MAPT
SCHEMBL28371329 0.93 KMT2A (0.61) KMT2ALMNAALDH1A1HSD17B10MAPT
SCHEMBL32685041 0.93 KMT2A (0.61) KMT2ALMNAALDH1A1HSD17B10MAPT
SCHEMBL13763455 0.93 KMT2A (0.61) KMT2ALMNAALDH1A1HSD17B10MAPT
SCHEMBL3504944 0.93 KMT2A (0.61) KMT2ALMNAALDH1A1HSD17B10MAPT
SCHEMBL32684886 0.93 KMT2A (0.61) KMT2ALMNAALDH1A1HSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250212873-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-07-03 US claimed
EP-4482306-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-01 EP claimed
WO-2023192424-A1 VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-05 WO claimed
US-20250212873-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-07-03 US disclosed
EP-4482306-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-01 EP disclosed
WO-2023192424-A1 VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-05 WO disclosed
US-20230047296-A1 Nrf2 REGULATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2023-02-16 US disclosed
CN-112601668-B Thermosensitive recording material and color-developing agent 索理思科技开曼公司 2022-07-29 CN disclosed
CN-111133086-A Compositions comprising odorants 丝趣科尔卡有限公司 2020-05-08 CN disclosed
US-9303176-B2 Hot melt ink composition, method for preparing a hot melt ink composition and use of a hot melt ink composition OCE-TECHNOLOGIES B.V. (NL) 2016-04-05 US disclosed
US-20150124030-A1 HOT MELT INK COMPOSITION, METHOD FOR PREPARING A HOT MELT INK COMPOSITION AND USE OF A HOT MELT INK COMPOSITION OCE-TECHNOLOGIES B.V. (NL) 2015-05-07 US disclosed
EP-0861242-A1 HETEROCYCLIC FUNGICIDES AgrEvo UK Limited (GB) 1998-09-02 EP disclosed
EP-0842685-A1 REACTION DISTILLATION APPARATUS AND REACTION DISTILLATION METHOD NIPPON SHOKUBAI CO., LTD. (JP) 1998-05-20 EP disclosed
EP-0684221-B1 Process for preparing carbonate esters NIPPON CATALYTIC CHEM IND (JP) 1997-10-15 EP disclosed
US-5663480-A Synthesis of aromatic carbonates by transesterification using a catalyst comprising a microporous material and a group IV metal NIPPON SHOKUBAI CO., LTD. (JP) 1997-09-02 US disclosed
WO-1997013762-A1 HETEROCYCLIC FUNGICIDES AGREVO UK LIMITED (GB) 1997-04-17 WO disclosed
US-5565605-A REACTING AN ESTER WITH AROMATIC ALCOHOL IN PRESENCE OF TRANSESTRIFICATION CATALYST TO FORM ARYL ESTER NIPPON SHOKUBAI CO., LTD. (JP) 1996-10-15 US disclosed
US-5543546-A ESTER INTERCHANGE OF CARBONATE ESTER AND AROMATIC HYDROXYCOMPOUND NIPPON SHOKUBAI CO., LTD. (JP) 1996-08-06 US disclosed
EP-0685455-A1 CATALYST FOR ARYL ESTER PRODUCTION AND PROCESS FOR PRODUCING ARYL ESTER THEREWITH NIPPON SHOKUBAI CO., LTD. (JP) 1995-12-06 EP disclosed
EP-0684221-A1 Process for preparing carbonate esters NIPPON SHOKUBAI CO., LTD. (JP) 1995-11-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230047296-A1 Nrf2 REGULATORS NFE2L2, KEAP1, NQO1 KMT2A 1751/4885LMNA 3312/4885ALDH1A1 621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.